Market Overview

Teleflex Introduces Innovative Technology for Lung Isolation Procedures

Related TFX
Teleflex Highlights Study involving ARROW® PICC with Chlorag+ard® Technology, Showing Significant Reduction in PICC-Related Bloodstream Infections
Teleflex Receives FDA Clearance For ARROW-ClarkTM VectorFlow Chronic Hemodialysis Catheter

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced today its Rusch^® EZ-Blocker^™ Disposable Endobronchial Blocker has received 510(k) clearance. The addition of the EZ-Blocker Endobronchial Blocker to the Teleflex Airway Management portfolio enhances the company's product offerings, which include clinically differentiated Rusch and Sheridan^® brands of endotracheal and endobronchial products.

Posted-In: News FDA

 

Related Articles (TFX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters